CANNABIS SUISSE CORP. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company's products include flavored broad-spectrum CBD oils and CBD isolate tinctures with no THC. It sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. The company also provides Cannabis Life, a mobile application based on an AI-chatbot that will have access to the most up-to-date information and find out data about companies and brands that sell seeds, cannabis types, etc. In addition, it offers health-related supplements, and retail branded cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. is based in Jacksonville, Florida.
CANNABIS SUISSE CORP. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review CANNABIS SUISSE CORP. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
CANNABIS SUISSE CORP. Competitors
CANNABIS SUISSE CORP. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans